Exicure, Inc. (XCUR)
NASDAQ: XCUR · IEX Real-Time Price · USD
0.480
-0.020 (-4.00%)
At close: Jul 26, 2024, 4:00 PM
0.513
+0.033 (6.88%)
After-hours: Jul 26, 2024, 6:08 PM EDT

Exicure Revenue

Exicure had revenue of $500.00K in the quarter ending March 31, 2024. This brings the company's revenue in the last twelve months to $500.00K, down -98.10% year-over-year.

Revenue (ttm)
$500.00K
Revenue Growth
-98.10%
P/S Ratio
8.31
Revenue / Employee
$83,333
Employees
6
Market Cap
4.15M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 202228.83M29.31M-6,068.12%
Dec 31, 2021-483.00K-17.10M-102.91%
Dec 31, 202016.61M15.32M1,181.87%
Dec 31, 20191.30M1.18M998.31%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evoke Pharma 6.11M
Genetic Technologies 5.78M
Intelligent Bio Solutions 3.21M
Trevena 3.14M
OpGen 2.67M
Soligenix 699.21K
Sonnet BioTherapeutics Holdings 92.73K
Revenue Rankings